Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;54(5):e14387.
doi: 10.1111/and.14387. Epub 2022 Jan 29.

Relationship of interleukin-23 with matrix metalloproteinase-9, pentraxin-3, sleep quality and prostate size in benign prostatic hyperplasia

Mathiyazhagan Navaneethakannan  1 , Hanumanthappa Nandeesha  1 , Sreerag K Sreenivasan  1
Affiliations

Relationship of interleukin-23 with matrix metalloproteinase-9, pentraxin-3, sleep quality and prostate size in benign prostatic hyperplasia

Mathiyazhagan Navaneethakannan et al. Andrologia. 2022 Jun.

Abstract

Benign prostatic hyperplasia (BPH) is known to be associated with sleep disturbance and inflammation. The objective of the study was to assess the levels of serum MMP-9 and its inhibitor (TIMP-1), interleukin-23 and pentraxin-3 and their association with sleep quality index and prostate size in BPH patients. Eighty-eight BPH patients were recruited based on clinical and ultrasound findings. MMP-9 and its inhibitor (TIMP-1), interleukin-23 and pentraxin-3 were estimated in all the subjects. Sleep quality was assessed using Pittsburgh Sleep Quality Index (PQSI). Interleukin-23 was significantly correlated with prostate size (p = 0.031), TIMP-1 (p = 0.035), MMP-9 (p = 0.004) and PSQI score (p = 0.020). TIMP-1 was significantly correlated with MMP-9 (p = 0.006) and prostate size (p = 0.016). Pentraxin-3 was positively correlated with PSQI score (p = 0.047). Multivariate analysis shows that interleukin -23 (p = 0.006) predicts prostate enlargement in BPH patients. Interleukin-23 was significantly increased in BPH patients with PSQI score >9 compared to those with PSQI <9. We conclude that poor sleep quality contributes to inflammation in BPH. Inflammation leads to prostate enlargement in patients with BPH.

Keywords: benign prostatic hyperplasia; inflammation; matrix metalloproteinase; sleep quality.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

REFERENCES

    1. Alhasani, S., & Yousif, N. (2013). Critical role of IL-23 signaling in prostatic cancer. American Journal of BioMedicine, 1, 4-6. https://doi.org/10.18081/ajbm/2333-5106-013-11/4-6
    1. Arivazhagan, J., Nandeesha, H., Dorairajan, L. N., & Sreenivasulu, K. (2017). Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia. The Aging Male, 20, 115-118. https://doi.org/10.1080/13685538.2017.1284778
    1. Baspinar, S., Bircan, S., Ciris, M., Karahan, N., & Bozkurt, K. K. (2017). Expression of NGF, GDNF and MMP-9 in prostate carcinoma. Pathology - Research and Practice, 213, 483-489. https://doi.org/10.1016/j.prp.2017.02.007
    1. Branche, B. L., Howard, L. E., Moreira, D. M., Roehrborn, C., Castro-Santamaria, R., Andriole, G. L., Hopp, M. L., & Freedland, S. J. (2018). Sleep problems are associated with development and progression of lower urinary tract symptoms: Results from REDUCE. Journal of Urology, 199, 536-542. https://doi.org/10.1016/j.juro.2017.08.108
    1. Calcinotto, A., Spataro, C., Zagato, E., Di Mitri, D., Gil, V., Crespo, M., De Bernardis, G., Losa, M., Mirenda, M., Pasquini, E., Rinaldi, A., Sumanasuriya, S., Lambros, M. B., Neeb, A., Lucianò, R., Bravi, C. A., Nava-Rodrigues, D., Dolling, D., Prayer-Galetti, T., … Alimonti, A. (2018). IL-23 secreted by myeloid cells drives castration- resistant prostate cancer. Nature, 559, 363-369. https://doi.org/10.1038/s41586-018-0266-0